World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
13039
World Ranking
4474
National Ranking
48

Overview

Eyad Elkord is affiliated with Xi'an Jiaotong-Liverpool University in China and has a significant body of research spanning medicine, immunology, and molecular biology. Their work focuses primarily on immune mechanisms and cancer, with particular emphasis on immunotherapy and biomarker discovery.

The main fields of study in Elkord's research include:

  • Medicine
  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology

Within these broader fields, subfields of study cover:

  • Immunology
  • Oncology
  • Molecular Biology
  • Cancer Research
  • Infectious Diseases

Elkord's research extensively addresses topics such as:

  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • COVID-19 Clinical Research Studies
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • MicroRNA in disease regulation

Frequent publication venues include:

  • Vaccines
  • Cancer Immunology Immunotherapy
  • Frontiers in Immunology
  • International Immunopharmacology
  • Clinical Immunology

Some of the recent papers by Elkord are:

  • FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets, 2020, Cancer Letters
  • T-cell responses and therapies against SARS-CoV-2 infection, 2020, Immunology
  • Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19, 2020, Cells
  • Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer, 2020, Cancer Immunology Immunotherapy
  • Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression, 2020, Frontiers in Immunology

Elkord has collaborated frequently with multiple coauthors, including:

  • Salman M. Toor
  • Varun Sasidharan Nair
  • Reem Saleh
  • Khaled Murshed
  • Mohamed Abu Nada

Best Publications

  • Immune checkpoint inhibitors: recent progress and potential biomarkers.

    Pramod Darvin;Salman M. Toor;Varun Sasidharan Nair;Eyad Elkord;Eyad Elkord

  • Immune evasion in cancer: Mechanistic basis and therapeutic strategies

    Dass S. Vinay;Elizabeth P. Ryan;Graham Pawelec;Wamidh H. Talib

  • Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity

    Appalaraju Jaggupilli;Eyad Elkord;Eyad Elkord

  • Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting

    Belal Chaudhary;Eyad Elkord

  • Designing a broad-spectrum integrative approach for cancer prevention and treatment

    Keith I. Block;Charlotte Gyllenhaal;Leroy Lowe;Amedeo Amedei

  • Immune checkpoint inhibitors in cancer therapy: a focus on T‐regulatory cells

    Varun Sasidharan Nair;Eyad Elkord;Eyad Elkord

  • FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets.

    Reem Saleh;Eyad Elkord;Eyad Elkord

  • Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

    Christy Ralph;Eyad Elkord;Deborah J. Burt;Jackie F. O'Dwyer

  • Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

    Sai Daayana;Eyad Elkord;U Winters;M Pawlita

  • Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression

    Reem Saleh;Eyad Elkord;Eyad Elkord

  • Neuropilin 1: function and therapeutic potential in cancer.

    Belal Chaudhary;Yazan S. Khaled;Yazan S. Khaled;Basil J. Ammori;Basil J. Ammori;Eyad Elkord;Eyad Elkord;Eyad Elkord

  • Myeloid-derived suppressor cells in cancer: recent progress and prospects

    Yazan S Khaled;Basil J Ammori;Eyad Elkord

  • Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

    Richard W Griffiths;Eyad Elkord;David E Gilham;Vijay A C Ramani

  • Immune checkpoints in the tumor microenvironment.

    Salman M Toor;Varun Sasidharan Nair;Julie Decock;Eyad Elkord;Eyad Elkord

  • Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells.

    Eyad Elkord;Paul E. Williams;Howard Kynaston;Anthony W. Rowbottom

  • Treg-mediated acquired resistance to immune checkpoint inhibitors.

    Reem Saleh;Eyad Elkord

  • Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.

    Hibah Shaath;Radhakrishnan Vishnubalaji;Eyad Elkord;Nehad M. Alajez

  • T cell responses and therapies against SARS-CoV-2 infection

    Salman M Toor;Reem Saleh;Varun Sasidharan Nair;Rowaida Z Taha

  • Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells.

    Varun Sasidharan Nair;Salman M. Toor;Bassam R. Ali;Eyad Elkord

  • Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.

    Yazan S. Khaled;Basil J. Ammori;Eyad Elkord

  • T regulatory cells in cancer: recent advances and therapeutic potential

    Eyad Elkord;Erik M Alcantar-Orozco;Simon J Dovedi;Dat Q Tran

Frequent Co-Authors

Robert E. Hawkins
Robert E. Hawkins University of Manchester
Peter L. Stern
Peter L. Stern University of Manchester
Jan W. Drijfhout
Jan W. Drijfhout Leiden University Medical Center
Ranad Shaheen
Ranad Shaheen King Faisal Specialist Hospital & Research Centre
Maria Rosa Ciriolo
Maria Rosa Ciriolo University of Rome Tor Vergata
William G. Helferich
William G. Helferich University of Illinois at Urbana-Champaign
Katia Aquilano
Katia Aquilano University of Rome Tor Vergata
Graham Pawelec
Graham Pawelec University of Tübingen
Alexandros G. Georgakilas
Alexandros G. Georgakilas National Technical University of Athens
Shahab Uddin
Shahab Uddin Hamad Medical Corporation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can significantly broaden career opportunities. Many aspiring healthcare professionals consider accelerated pathways like the accelerated RN to NP programs to quickly transition into advanced nursing roles. These programs offer a streamlined approach for registered nurses seeking nurse practitioner qualifications without spending extra years in school.

For individuals without a nursing background interested in entering the field, online options such as online RN programs for non nurses provide accessible pathways. These programs help non-nurses gain foundational nursing skills to build careers in healthcare with flexibility.

If you are aiming to obtain a Bachelor of Science in Nursing quickly, investigating the easiest ABSN program to get into may be beneficial. These programs offer entry pathways with less competitive admission requirements, helping prospective nurses advance faster.

For advanced practice roles, acquiring an acute care nurse practitioner certification is essential for those focused on critical care specialties. This certification can unlock opportunities in hospital and specialized clinical settings, complementing immunology expertise.

Best Scientists Citing Eyad Elkord

Trending Scientists